Uncategorized

The registration initiative launched by Sanochemia Pharmazeutika in 2021, together with the continuously increasing market demand, has led to a record volume of orders.

Sanochemia Pharmazeutika secures exclusive licensing rights to a new MRI contrast agent based on ferumoxtran, that is in an advanced pivotal trial in clinical phase III and may be used to detect the smallest lymph node metastases in prostate cancer patients. The product is already deployed in the Netherlands within an authorized Named-Patient-Use-Program (Artsenverklaring).

Sanochemia Pharmazeutika is strengthening its position in the field of medical imaging with an exclusive product license for a MRI contrast agent based on iron-containing nanoparticles under the brand name Resotran®.

Sanochemia Pharmazeutika is taking the green transition as an opportunity and takes a leap towards sustainability with a new photovoltaic (PV) facility.

For Sanochemia, joint development with employees is an important cornerstone of entrepreneurial activities. It is therefore particularly gratifying that some of Sanochemia's apprentices were honored for their special achievements: In…

Sanochemia aims to continuously grow its business and step-up partnerships for the future. Joint development with partner companies and employees are seen an important cornerstone of Sanochemia´s entrepreneurial activities. In…

SANOCHEMIA Pharmazeutika continues its strong commitment in combating the pandemic and launches a cooperation with the Province of Burgenland and Haemo Pharma. To increase regional PCR testing capacities, a dedicated…

As a global Contract Development and Manufacturing Organization (CDMO), SANOCHEMIA provides a broad and high-quality offering with a "FULL-Service" concept for a long time. Customers and partners benefit from access…

CPhI Worldwide von 9-11 November in Milano

High-performance production no longer means more of the same, as in the past, but more variety and flexibility. However, increasing production requirements must not mean that the demand for product quality is lost. SANOCHEMIA demonstrates precisely this highly competitive combination of flexible production and top product quality: agile innovation processes, investment in new production facilities and high quality standards make it possible.